Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit? - a podcast by ReachMD

CME credits: 0.25

Valid until: 01-12-2024

Claim your CME credit at https://reachmd.com/programs/cme/addressing-issues-of-cv-mortality-in-clinical-trials-with-iv-iron-are-we-still-getting-a-medical-benefit/15333/

Iron deficiency is a common heart failure comorbidity with a negative impact on patients’ quality of life and mortality. Recent world events may have influenced clinical trial outcomes with IV iron in heart failure, and secondary analysis has become commonplace. Are the findings still clinically relevant, and are we still getting a clinical benefit? Join Drs. Stefan Anker, Piotr Ponikowski, and John Cleland as they differentiate the design of IV iron trials and break down the relevance of key clinical endpoints. Are we still asking the right questions?

=

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD